Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001994842 | SCV002231235 | pathogenic | not provided | 2022-02-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with clinical features of EYS-related conditions (PMID: 31054281). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu1552*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). |
Baylor Genetics | RCV003471143 | SCV004195853 | likely pathogenic | Retinitis pigmentosa 25 | 2022-02-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003471143 | SCV005670604 | likely pathogenic | Retinitis pigmentosa 25 | 2023-12-29 | criteria provided, single submitter | clinical testing |